Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX6ORJ
|
||||
| Drug Name |
(R)-2-amino-4-(3-(cyclopropylethynyl)phenyl)-4-(4-(difluoromethoxy)phenyl)-1-methyl-1H-imidazol-5(4H)-one
|
||||
| Synonyms |
CHEMBL1271246
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C22H19F2N3O2
|
||||
| Canonical SMILES |
CN1C(=N[C@](C1=O)(c2ccc(OC(F)F)cc2)c3cccc(c3)C#CC4CC4)N
|
||||
| InChI |
InChI=1S/C22H19F2N3O2/c1-27-19(28)22(26-21(27)25,16-9-11-18(12-10-16)29-20(23)24)17-4-2-3-15(13-17)8-7-14-5-6-14/h2-4,9-14,20H,5-6H2,1H3,(H2,25,26)/t22-/m1/s1
|
||||
| InChIKey |
WQGSTVFPWRFZTI-JOCHJYFZSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Renin, renal | Target Info | [1587926] | ||
| Cathepsin D | Target Info | [1587926] | |||
| BioCyc Pathway | Thyroid hormone biosynthesis | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| Pathway Interaction Database | LKB1 signaling events | ||||
| Ceramide signaling pathway | |||||
| Direct p53 effectors | |||||
| Validated nuclear estrogen receptor alpha network | |||||
| PathWhiz Pathway | Angiotensin Metabolism | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.